Chongqing Xishan Science and Technology Co Ltd

SHSE:688576 (China)   Ordinary Shares - Class A
Â¥ 69.00 (+0.69%) Oct 23
27.71
P/B:
1.76
Market Cap:
Â¥ 3.66B ($ 512.01M)
Enterprise V:
Â¥ 2.32B ($ 313.84M)
Volume:
25.08M
Avg Vol (2M):
562.32K
Trade In:
Volume:
25.08M
Avg Vol (2M):
562.32K

Business Description

Description
Chongqing Xishan Science and Technology Co Ltd focuses on surgical instruments, especially in the field of minimally invasive surgical instruments. It is mainly engaged in the research, development, production and sales of minimally invasive surgical instruments. Speculum, energy surgery equipment and other products, currently the products are mainly used in neurosurgery, ENT, orthopedics, breast surgery and other clinical departments. The company's main products are surgical power units, consumables and accessories, which are mainly used for cutting, grinding, planing, sawing, milling and trimming of bone tissue and soft tissue in surgical operations, especially minimally invasive surgical operations.
Name Current Vs Industry Vs History
Cash-To-Debt 1334.43
Equity-to-Asset 0.93
Debt-to-EBITDA 0.01
Interest Coverage 916.01
Piotroski F-Score 4/9
0
1
2
3
4
5
6
7
8
9
Altman Z-Score 14.91
Distress
Grey
Safe
Beneish M-Score 15.18
Manipulator
Not Manipulator
WACC vs ROIC
WACC
ROIC

Momentum Rank

Name Current Vs Industry Vs History
5-Day RSI 60.97
9-Day RSI 62.65
14-Day RSI 62.71
6-1 Month Momentum % -30.38
12-1 Month Momentum % -36.94

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 10.1
Quick Ratio 9.63
Cash Ratio 8.96
Days Inventory 221.34
Days Sales Outstanding 47.28
Days Payable 248.76
Income Statement Breakdown FY
No Enough Data
Balance Sheet Breakdown
No Enough Data
Cashflow Statement Breakdown
No Enough Data

Historical Operating Revenue by Business Segment

Historical Operating Revenue by Geographic Region

5-Step DuPont Analysis as of
No Enough Data

Guru Trades

See Details
To

Insider Trades

See Details
To

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To

Performance

Dividend
Log
Bar
To

Annualized Return %  

Symbol
1 Week
1 Month
3 Months
6 Months
YTD
1 Year
3 Years
5 Years
10 Years

Total Annual Return %  

Symbol
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015

Chongqing Xishan Science and Technology Co Ltd Executives

Details

Valuation Chart

Year:

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil ¥) 364.529
EPS (TTM) (Â¥) 2.49
Beta 0
Volatility % 41.58
14-Day RSI 62.71
14-Day ATR (Â¥) 3.002279
20-Day SMA (Â¥) 62.1085
12-1 Month Momentum % -36.94
52-Week Range (Â¥) 48.6 - 99.7
Shares Outstanding (Mil) 53

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 4
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

Chongqing Xishan Science and Technology Co Ltd Filings

Filing Date Document Date Form
No Filing Data

Chongqing Xishan Science and Technology Co Ltd Stock Events

Financials Calendars
Event Date Price(Â¥)
No Event Data

Chongqing Xishan Science and Technology Co Ltd Frequently Asked Questions

What is Chongqing Xishan Science and Technology Co Ltd(SHSE:688576)'s stock price today?
The current price of SHSE:688576 is ¥69.00. The 52 week high of SHSE:688576 is ¥99.70 and 52 week low is ¥48.60.
When is next earnings date of Chongqing Xishan Science and Technology Co Ltd(SHSE:688576)?
The next earnings date of Chongqing Xishan Science and Technology Co Ltd(SHSE:688576) is .
Does Chongqing Xishan Science and Technology Co Ltd(SHSE:688576) pay dividends? If so, how much?
The  Dividend Yield %  of Chongqing Xishan Science and Technology Co Ltd(SHSE:688576) is 1.44% (As of Today), Highest Dividend Payout Ratio of Chongqing Xishan Science and Technology Co Ltd(SHSE:688576) was 0. The lowest was 0. And the median was 0. The  Forward Dividend Yield % of Chongqing Xishan Science and Technology Co Ltd(SHSE:688576) is 1.44%. For more information regarding to dividend, please check our Dividend Page.

Press Release

Subject Date
No Press Release